Design and synthesis of fluorescent SGLT2 inhibitors |
| |
Authors: | Lansdell Mark I Burring Denise J Hepworth David Strawbridge Matthew Graham Emily Guyot Thierry Betson Mark S Hart James D |
| |
Institution: | Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Kent CT139NJ, UK. mark.lansdell@pfizer.com |
| |
Abstract: | The design and synthesis of the first fluorophore-conjugated SGLT2 inhibitors is described. The mode of linking the fluorophore to the SGLT2 pharmacophore was found to be crucial in achieving optimum potency. Superior potency to phlorizin was provided by examples containing TAMRA, BODIPY, Cy3B and NBD fluorophores. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |